Data-Driven Precision Medical Service Market Report 2026

The data-driven precision medical service market size has grown rapidly in recent years. It will grow from $165.24 billion in 2025 to $198.28 billion in 2026 at a compound annual growth rate (CAGR) of 20%. The growth in the historic period can be attributed to increasing digitization of healthcare records, growth in genomic data availability, rising adoption of analytics-driven care models, expansion of healthcare IT infrastructure, increasing collaboration between tech and healthcare providers.

The data-driven precision medical service market size is expected to see rapid growth in the next few years. It will grow to $407.17 billion in 2030 at a compound annual growth rate (CAGR) of 19.7%. The growth in the forecast period can be attributed to increasing investments in ai-powered healthcare platforms, rising demand for personalized treatment pathways, expansion of real-time clinical decision support, growing adoption of wearable health data integration, increasing focus on preventive precision medicine. Major trends in the forecast period include increasing adoption of AI-driven clinical analytics, growing integration of multi-omics data platforms, expansion of cloud-based precision medicine services, rising use of predictive healthcare models, enhanced focus on outcome-based care.

The increasing adoption of cloud-based solutions is expected to drive the growth of the data-driven precision medical service market in the coming years. Cloud-based solutions are software, platforms, or infrastructure delivered over the internet, providing on-demand access, storage, and computing without the need for local installation. Their adoption is fueled by scalability, allowing healthcare organizations to quickly adjust computing resources according to demand without large upfront infrastructure investments. This scalability supports real-time patient data analysis, predictive modeling, and personalized care. For example, according to Ace Cloud, a U.S.-based cloud computing provider specializing in healthcare applications, 95% of healthcare organizations now use cloud technology for patient data management, and in 2025, cloud adoption in healthcare increased 41% year-over-year, representing the fastest growth among all industry sectors. Thus, the rising adoption of cloud-based solutions is expected to propel the data-driven precision medical service market.

Leading companies in the data-driven precision medical service market are increasingly focusing on innovations such as deep learning for multi-omics discovery to accelerate biomarker identification, optimize personalized treatment strategies, and enhance clinical decision-making in oncology and other therapeutic areas. Deep learning for multi-omics discovery uses AI algorithms to analyze complex genomic, epigenomic, transcriptomic, and proteomic data, enabling the identification of new biomarkers and therapeutic targets. For instance, in January 2023, Guardant Health, a U.S.-based biotechnology company, launched Guardant Galaxy, a comprehensive suite of advanced analytical tools. Developed through internal research and external collaborations, this platform enhances the accuracy and clinical utility of Guardant Health’s cancer testing portfolio. By integrating advanced analytics, Guardant Galaxy supports more precise patient diagnostics, personalized treatment planning, and the accelerated discovery of novel biomarkers and therapeutic targets, driving the next generation of drug development.

In July 2025, Samsung Electronics, a South Korea-based consumer electronics company, acquired Xealth for an undisclosed amount. This acquisition aims to strengthen Samsung’s connected care platform by integrating wearable-generated consumer health data with Xealth’s digital health orchestration, bridging wellness tools and clinical decision workflows within electronic health records. Xealth, a U.S.-based provider, offers a data-driven platform that enables health systems to deliver precision medical services by integrating various digital health tools.

Major companies operating in the data-driven precision medical service market are Samsung Electronics Co. Ltd., Roche Holding AG, Novartis AG, Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina Inc., BioNTech SE, QIAGEN N.V., Natera Inc., Precision Medicine Group Inc., Guardant Health Inc., Tempus Labs Inc., Flatiron Health Inc., Certara L.P., Verily Life Sciences LLC, GenomOncology Inc., SOPHiA GENETICS SA, Recursion Pharmaceuticals Inc., DNAnexus Inc., Biomea Fusion Inc.

North America was the largest region in the data-driven precision medical service market in 2025. The regions covered in the data-driven precision medical service market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the data-driven precision medical service market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Tariffs are impacting the data-driven precision medical service market by increasing costs of imported servers, cloud infrastructure hardware, advanced analytics software licenses, and connected medical devices. Healthcare systems in North America and Europe are most affected due to reliance on imported digital infrastructure, while Asia-Pacific faces higher costs for platform deployment. These tariffs are increasing implementation expenses and delaying large-scale rollouts. However, they are also encouraging domestic cloud infrastructure development, localized data centers, and regional innovation in healthcare analytics solutions.

The data-driven precision medical service market research report is one of a series of new reports that provides data-driven precision medical service market statistics, including data-driven precision medical service industry global market size, regional shares, competitors with a data-driven precision medical service market share, detailed data-driven precision medical service market segments, market trends and opportunities, and any further data you may need to thrive in the data-driven precision medical service industry. This data-driven precision medical service market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

Data-driven precision medical service refers to healthcare solutions that utilize patient-specific data, advanced analytics, and computational tools to provide highly personalized diagnosis, treatment, and preventive care. This approach combines genomic, clinical, and lifestyle information to optimize medical decision-making and improve patient outcomes.

The primary types of data-driven precision medical services are cloud-based and on-premises. Cloud-based solutions are hosted on secure platforms, offering scalable storage, real-time access, and advanced analytics of patient health data. These services incorporate technologies such as artificial intelligence and machine learning, big data analytics, genomics and sequencing, cloud computing, blockchain, digital twin technology, wearables, and the Internet of Things (IoT). They are implemented across diverse healthcare settings, including hospitals, clinics, and other medical facilities, supporting more personalized, efficient, and data-driven patient care.

The data-driven precision medical service market includes revenues earned by entities through genomic-based services, predictive analytics services, and clinical decision support services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.